Bridgewater Associates LP acquired a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 19,054 shares of the company's stock, valued at approximately $1,265,000.
Other institutional investors have also added to or reduced their stakes in the company. FMR LLC grew its holdings in Ryan Specialty by 72.3% during the 3rd quarter. FMR LLC now owns 12,875 shares of the company's stock worth $855,000 after acquiring an additional 5,402 shares during the period. Quantbot Technologies LP boosted its position in shares of Ryan Specialty by 34.8% during the 3rd quarter. Quantbot Technologies LP now owns 107,418 shares of the company's stock valued at $7,131,000 after purchasing an additional 27,732 shares in the last quarter. Loomis Sayles & Co. L P grew its stake in Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock worth $91,000 after purchasing an additional 286 shares during the period. SevenBridge Financial Group LLC bought a new stake in Ryan Specialty in the third quarter worth approximately $438,000. Finally, Great Valley Advisor Group Inc. acquired a new position in Ryan Specialty in the third quarter valued at approximately $346,000. 84.82% of the stock is currently owned by institutional investors.
Insider Transactions at Ryan Specialty
In other Ryan Specialty news, Director David P. Bolger sold 7,055 shares of the business's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company's stock, valued at $884,236.54. The trade was a 54.42 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.
Ryan Specialty Stock Down 1.8 %
Shares of RYAN stock traded down $1.36 during trading hours on Monday, reaching $74.04. The company had a trading volume of 669,590 shares, compared to its average volume of 868,293. The business has a fifty day simple moving average of $70.23 and a 200-day simple moving average of $63.41. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.97. The company has a market cap of $19.39 billion, a price-to-earnings ratio of 96.61, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same period in the prior year, the firm posted $0.32 EPS. The firm's quarterly revenue was up 20.5% compared to the same quarter last year. On average, research analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.
Ryan Specialty Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.59%. Ryan Specialty's dividend payout ratio is currently 57.14%.
Analyst Ratings Changes
Several analysts have recently commented on the stock. Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 10th. Bank of America lifted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. Barclays increased their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research report on Thursday, November 21st. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. Finally, UBS Group increased their price target on Ryan Specialty from $67.00 to $76.00 and gave the stock a "buy" rating in a report on Tuesday, August 13th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of "Hold" and a consensus target price of $71.67.
Get Our Latest Analysis on RYAN
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.